NeuroPace Inc (NPCE)

NASDAQ

$15.46

NeuroPace, Inc. is a medical device company in the United States. The company is headquartered in Mountain View, California.

Sector:

Industry:

68 analysts

Buy

Target: $20 (+29.37%)

Market Cap

$550M

Free Cash Flow Yield

-1.79%

Beta (5Y)

1.19

Adjust inflation

Log

Valuation

Market Cap$550M

P/S5.55

P/B37.36

Profitability

Total Revenue (TTM)$100M

Gross Profit (TTM)$78M

EBITDA-$17M

Profit Margin-30.3%

Operating Margin-25.2%

EPS-$0.65

Financial Health

Debt-to-Equity408.3%

Free Cash Flow Yield-1.79%

Growth & Risk

Revenue 5Y CAGR+18.62%

FCF 5Y CAGR-14.14%

Beta (5Y)1.19

Sharpe Ratio1.10